GeneDx
Darrow Speyer, MGC, LCGC, currently serves as the Head of Training and Sales Enablement at GeneDx since March 2024. Prior to this role, Darrow held several positions at Invitae from November 2018 to March 2024, including Senior Sales Trainer for Rare Disease and Client Relationship Manager. Darrow's earlier experience at GeneDx from August 2015 to November 2018 involved work as a Genetic Testing Specialist and Genetic Counselor. Additionally, Darrow worked as a Pediatric and Prenatal Genetic Counselor at the University of South Florida from September 2013 to July 2015 and as a Prenatal Genetic Counselor at Mercy Medical Center in Baltimore, MD, from June 2012 to September 2013. Educational qualifications include a Master's Degree in Genetic Counseling from the University of Maryland School of Medicine (2010-2012) and a Bachelor's Degree in Psychology and Biology from Florida State University (2005-2009).
This person is not in any teams
This person is not in any offices
GeneDx
10 followers
GeneDx is focused on delivering personalized, actionable insights that improve health outcomes. We sit at the intersection of diagnostics and data science, pairing decades of genomic expertise with an unmatched ability to interpret clinical data at scale. Our exome and genome testing is among the best in the industry. We expect that it will be even more advanced in the future with the help of Centrellis®, our innovative health information platform. Powered by millions of medical records, Centrellis® integrates digital tools with artificial intelligence to ingest and synthesize clinical and genomic data. As a result of our robust test menu, including our exome and genome testing, and the comprehensive insights generated by Centrellis®, we are developing a more complete understanding of complex disease than ever before. This translates to faster diagnosis, more effective treatment plans, and enhanced drug discovery. Our offerings help a whole spectrum of healthcare partners -- clinicians, researchers, health systems, pharmaceutical companies, and payors -- improve patient experiences and advance population health.